Biotechnology and Services Laboratory

Printer-friendly version

 

The biotechnology laboratory of Camellix, LLC is located in the Georgia Health Sciences University (GHSU) Center of Innovation for Life Sciences, Augusta, GA.  The main function of the laboratory is the investigation of various naturally-occurring agents for future therapeutic use.  The laboratory uses the most advanced technologies and biological models available to test the biological effects of agents, and has the potential to conduct clinical studies of candidate therapeutic agents within the medical centers associated with the university.

Camellix, LLC is able to provide contract services to government and industrial entities requiring testing of agents with biological functions. Specifically, we offer toxicity tests of materials in cell culture systems and small animal models; we also conduct release assays of materials in post-surgery animal models to understand the release time and organ/tissue distribution of a specific material (i.e. protein or molecule that can be labeled).  These specific tests can be used to evaluate a new material or molecule for anti-microbial, anti-inflammatory, anti-cancer, tissue regenerative, bone growth, and other biological or therapeutic functions.

Out experts are able to test for:

  1. Potential anti-cancer agents. In order to test material or molecules that destroys cancer cells but not normal cells, we will use specific cancer cell lines paired with normal primary cells to determine if an agent possesses anti-cancer property. If it does, we are able to test the agent in animal models, such as cancer xenograft nude mice model and chemically-induced cancer model.
  2. Potential biological agents. A biological agent may help to grow bones, heal wounds, or reduce inflammation. We are able to determine if an agent has such properties by using specific animal models, such as bone graft model, wound healing model, or models for inflammatory diseases.
  3. Potential anti-microbial agents. We can determine if an agent exerts anti-bacterial or anti-viral properties in established laboratory systems. We have experience with such tests from simple plaque formation to clinical trials.
  4. Potential anti-oxidant agents. We can use either cell culture systems or animal models to determine if an agent has anti-oxidant properties, in comparison to know anti-oxidants, such as green tea polyphenols or vitamin E.
  5. Potential drugs for autoimmune diseases. We are experienced in animal models for type-1 diabetes, Sjogren’s syndrome, and psoriasis. These established animal models can be used to test potential drugs targeting these diseases/organ/tissues.

We are highly experienced in cell culture and the use of animal models to test various agents and their biological mechanisms.  In addition, Camellix, LLC has established working relationship with law firms that specialize in FDA and corporate law.

To provide these high quality services, Camellix employs its own staff, and subcontracts to a network of university faculty, all supported by a strong consulting group. Many members are university faculty with highly recognized achievements, and a track record of government and industrial grants. These individuals are all specialists with expertise and  experience in cell and molecular biology, microbiology, bio-materials, cancer biology, autoimmune diseases, inflammation, and other areas related to human health.

The combined knowledge and resources of Camellix, LLC and its associates provides a strong and unique platform to address the complex issues involved in the development of new agents, materials, methods and approaches for enhancing human health and treating human diseases.

For more information, please contact Dr. Stephen Hsu at: shsu@camellix.com